Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review
Crossref DOI link: https://doi.org/10.1007/s00277-015-2585-7
Published Online: 2016-01-12
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Howard, Scott C.
Trifilio, Steven
Gregory, Tara K.
Baxter, Nadine
McBride, Ali
Funding for this research was provided by:
Sanofi (US)
Text and Data Mining valid from 2016-01-12